Salix Coronary Plaque vs A View LCS
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A is highly specialized for detailed coronary artery plaque and stenosis assessment from CCTA scans, focusing on comprehensive coronary artery disease diagnosis. Tool B provides a broader thoracic CT analysis, including lung cancer screening and emphysema quantification, while also offering coronary artery calcium scoring from low-dose CT scans. They are adjacent competitors, with a partial overlap in cardiovascular risk assessment through calcium scoring, but distinct primary applications and analytical depth.
Choose Salix Coronary Plaque if…
Choose Salix Coronary Plaque if your primary focus is rapid, near real-time, point-of-care assessment of coronary artery plaque and stenosis directly from CCTA scans. This tool is ideal for clinicians requiring detailed quantification of plaque features, including high-risk characteristics, to aid in the immediate diagnosis and management of coronary artery disease.
View Salix Coronary Plaque →Choose A View LCS if…
Choose A View LCS if you require a comprehensive AI-powered platform for multi-modal thoracic CT analysis, particularly from low-dose CT scans. This tool is best suited for programs focused on lung cancer screening, where it can simultaneously provide automated lung nodule detection, emphysema quantification, and coronary artery calcification scoring from a single scan.
View A View LCS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Salix Coronary Plaque | A View LCS |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | Cloud | Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker). It can also be integrated into standard reading environments (PACS), RIS (Radiological Information System), or used as a standalone third-party application or web-based application. |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Salix Coronary Plaque | A View LCS |
|---|---|---|
| Product Name | Salix Coronary Plaque | A View LCS |
| Company | Artrya Limited | Coreline Soft Co. |
| Primary Clinical Focus | AI-driven, web-based software for near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease (Cardiology AI). | AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan (Cardiology AI, Oncology AI, Radiology & Imaging AI). |
| Coronary Artery Calcium (CAC) Scoring | Quantification of calcifications (calcium scoring) | CAC scoring (Agatston, volume, mass), Segmentation of major coronary arteries |
| Coronary Plaque Analysis | Detection and quantification of coronary plaque (atherosclerosis), Identification of high-risk plaque features (e.g., low-attenuation plaque, spotty calcification, positive remodeling, napkin-ring sign), Stenosis assessment. | Not specified |
| Lung Nodule Detection | Not specified | Automated lung nodule detection and classification, Nodule volume quantification and measurement (3D), Lung-RADS scoring and reporting. |
| Emphysema Analysis | Not specified | Emphysema analysis and quantification (LAA) |
Videos
Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and A View LCS.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Salix Coronary Plaque is designed for assessing coronary artery plaque and stenosis specifically from CCTA scans. AVIEW LCS performs coronary artery calcification detection from low-dose CT scans, in addition to its comprehensive thoracic analysis capabilities.
Salix Coronary Plaque provides detailed detection and quantification of coronary plaque, including high-risk features and stenosis assessment, from CCTA. AVIEW LCS focuses on Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass) and segmentation of major coronary arteries from low-dose CT scans.
Yes, Salix Coronary Plaque specifically identifies high-risk plaque features such as low-attenuation plaque, spotty calcification, positive remodeling, and the napkin-ring sign. AVIEW LCS focuses on general coronary artery calcium scoring.
Salix Coronary Plaque explicitly mentions a per-scan assessment model with a US CPT reimbursement rate of US$950 per assessment. AVIEW LCS does not provide specific reimbursement details, only stating 'contact for quote' for pricing.
Salix Coronary Plaque is solely focused on Cardiology AI for coronary artery disease. AVIEW LCS offers comprehensive thoracic CT analysis, including automated lung nodule detection and classification, Lung-RADS scoring, and emphysema analysis, in addition to its cardiology AI features.